DNA and RNA damage by Cu(II)-amikacin complex (Q44210380)

30 November 2017

DNA and RNA damage by Cu(II)-amikacin complex (English)

1 reference

30 November 2017

6

Wojciech Bal

1 reference

30 November 2017

4

Jerzy Ciesiołka

1 reference

30 November 2017

Małgorzata Jezowska-Bojczuk

1

1 reference

30 November 2017

Wojciech Szczepanik

2

1 reference

30 November 2017

Wojciech Leśniak

3

1 reference

30 November 2017

Jan Wrzesiński

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

269

1 reference

30 November 2017

22

1 reference

30 November 2017

5547-5556

1 reference

Molecular mechanism of hydrogen peroxide conversion and activation by Cu(II)-amikacin complexes.

30 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Insights into ototoxicity. Analogies to nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Aminoglycoside antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Copper and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

A novel assay of 8-oxo-2'-deoxyguanosine 5'-triphosphate pyrophosphohydrolase (8-oxo-dGTPase) activity in cultured cells and its use for evaluation of cadmium(II) inhibition of this activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Possible role of oxidative damage in metal-induced carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

The role of 8-hydroxyguanine in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Modulation of RNA function by aminoglycoside antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

The binding of antibiotics to RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Aminoglycoside-RNA interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

tRNA(Phe) binds aminoglycoside antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

RNA - ligand interactions:(I) magnesium binding sites in yeast tRNAPhe

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Structural analysis of spermine and magnesium ion binding to yeast phenylalanine transfer RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Probing the environment of lanthanide binding sites in yeast tRNA(Phe) by specific metal-ion-promoted cleavages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Pharmacokinetics of amikacin in infants and pre-school children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Serum concentrations and safety of single daily dosing of amikacin in children undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Intracellular iron, but not copper, plays a critical role in hydrogen peroxide-induced DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Coordination Chemical Studies of Some Polymeric Transition Metal Complexes with Neomycin and Their Biological Activity Uses. Indirect Determination of Neomycin by Atomic Absorption Spectroscopy (AAS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Delineation of conformational and structural features of the amikacin-Cu(II) complex in water solution by 13C-NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Copper(II) binding to tobramycin: potentiometric and spectroscopic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Oxidative Nucleobase Modifications Leading to Strand Scission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Site-specific DNA damage induced by NADH in the presence of copper(II): role of active oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Pharmacokinetics of once-daily amikacin in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

Copper is involved in hydrogen-peroxide-induced DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03260.X

10.1046/J.1432-1033.2002.03260.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference